CN114746551A - 大肠癌诊断用标志物、辅助大肠癌的诊断的方法、收集数据以用于大肠癌诊断的方法、大肠癌的诊断试剂盒、大肠癌治疗药物、大肠癌的治疗方法、大肠癌的诊断方法 - Google Patents

大肠癌诊断用标志物、辅助大肠癌的诊断的方法、收集数据以用于大肠癌诊断的方法、大肠癌的诊断试剂盒、大肠癌治疗药物、大肠癌的治疗方法、大肠癌的诊断方法 Download PDF

Info

Publication number
CN114746551A
CN114746551A CN202080057794.9A CN202080057794A CN114746551A CN 114746551 A CN114746551 A CN 114746551A CN 202080057794 A CN202080057794 A CN 202080057794A CN 114746551 A CN114746551 A CN 114746551A
Authority
CN
China
Prior art keywords
colorectal cancer
mir
hsa
marker
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080057794.9A
Other languages
English (en)
Chinese (zh)
Inventor
志村贵也
岩崎弘靖
片冈洋望
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagoya City University
Original Assignee
Nagoya City University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagoya City University filed Critical Nagoya City University
Publication of CN114746551A publication Critical patent/CN114746551A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN202080057794.9A 2019-08-16 2020-08-12 大肠癌诊断用标志物、辅助大肠癌的诊断的方法、收集数据以用于大肠癌诊断的方法、大肠癌的诊断试剂盒、大肠癌治疗药物、大肠癌的治疗方法、大肠癌的诊断方法 Pending CN114746551A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019149338 2019-08-16
JP2019-149338 2019-08-16
PCT/JP2020/030676 WO2021033605A1 (ja) 2019-08-16 2020-08-12 大腸癌診断用マーカー、大腸癌の診断を補助する方法、大腸癌の診断のためにデータを収集する方法、大腸癌の診断用キット、大腸癌治療薬、大腸癌の治療方法、大腸癌の診断方法

Publications (1)

Publication Number Publication Date
CN114746551A true CN114746551A (zh) 2022-07-12

Family

ID=74660946

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080057794.9A Pending CN114746551A (zh) 2019-08-16 2020-08-12 大肠癌诊断用标志物、辅助大肠癌的诊断的方法、收集数据以用于大肠癌诊断的方法、大肠癌的诊断试剂盒、大肠癌治疗药物、大肠癌的治疗方法、大肠癌的诊断方法

Country Status (5)

Country Link
US (1) US20220290249A1 (https=)
EP (1) EP4015635A4 (https=)
JP (1) JP7610265B2 (https=)
CN (1) CN114746551A (https=)
WO (1) WO2021033605A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024173418A1 (en) * 2023-02-16 2024-08-22 Infinitum Health, Llc Methods of inhibiting cancer growth and inhibiting viral infections

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120088687A1 (en) * 2010-10-08 2012-04-12 Baylor Research Institute MicroRNAs (miRNA) as Biomarkers for the Identification of Familial and Non-Familial Colorectal Cancer
US20120184453A1 (en) * 2011-01-13 2012-07-19 Industrial Technology Research Institute Biomarkers for recurrence prediction of colorectal cancer
US20130137593A1 (en) * 2010-04-15 2013-05-30 Hadasit Medical Research Services And Development Ltd. Early detection and staging of colorectal cancer using a panel of micro rnas
WO2015190586A1 (ja) * 2014-06-13 2015-12-17 東レ株式会社 大腸がんの検出キット又はデバイス及び検出方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103154236B (zh) * 2010-05-12 2016-08-31 再生医学Tx有限责任公司 生物活性肾细胞
WO2016186987A1 (en) * 2015-05-15 2016-11-24 Trustees Of Dartmouth College Biomarker micrornas and method for determining tumor burden
JP7281117B2 (ja) 2018-02-28 2023-05-25 東芝ライテック株式会社 照明器具

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130137593A1 (en) * 2010-04-15 2013-05-30 Hadasit Medical Research Services And Development Ltd. Early detection and staging of colorectal cancer using a panel of micro rnas
US20120088687A1 (en) * 2010-10-08 2012-04-12 Baylor Research Institute MicroRNAs (miRNA) as Biomarkers for the Identification of Familial and Non-Familial Colorectal Cancer
US20120184453A1 (en) * 2011-01-13 2012-07-19 Industrial Technology Research Institute Biomarkers for recurrence prediction of colorectal cancer
WO2015190586A1 (ja) * 2014-06-13 2015-12-17 東レ株式会社 大腸がんの検出キット又はデバイス及び検出方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KUN‑PING LI等: "Upregulation of miR‑598 promotes cell proliferation and cell cycle progression in human colorectal carcinoma by suppressing INPP5E expression", 《MOLECULAR MEDICINE REPORTS》, vol. 17, no. 2, pages 1 *
R VISHNUBALAJI等: "Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer", 《CELL DEATH AND DISEASE》, vol. 6, pages 2 *
YA‑NAN WANG等: "Novel circulating microRNAs expression profile in colon cancer: a pilot study", 《EUROPEAN JOURNAL OF MEDICAL RESEARCH》, vol. 22 *
罗琳;郭俊明;: "微小RNA-129在肿瘤发生中的作用机制", 中国生物化学与分子生物学报, no. 11 *

Also Published As

Publication number Publication date
JPWO2021033605A1 (https=) 2021-02-25
JP7610265B2 (ja) 2025-01-08
US20220290249A1 (en) 2022-09-15
WO2021033605A1 (ja) 2021-02-25
EP4015635A4 (en) 2023-10-25
EP4015635A1 (en) 2022-06-22

Similar Documents

Publication Publication Date Title
CN111961725B (zh) 胰腺癌的检测试剂盒或装置以及检测方法
JP6203209B2 (ja) 早期結腸直腸癌の検出のための血漿マイクロｒｎａ
JP6989863B2 (ja) 大腸癌の診断方法
EP2653546A2 (en) Marker for predicting stomach cancer prognosis and method for predicting stomach cancer prognosis
JP2019537436A (ja) 進行性胃癌患者の手術後の予後または抗癌剤適合性予測システム
BR112019011031A2 (pt) Método para estratificação de risco, produto de programa de computador, kit de diagnóstico e uso de um perfil de expressão gênica para estratificação de risco
US20190185945A1 (en) Biomarkers of Oral, Pharyngeal and Laryngeal Cancers
JP6608424B2 (ja) 前癌性結腸直腸ポリープおよび結腸直腸癌を特定するための方法およびキット
JP7610265B2 (ja) 大腸癌診断用マーカー、大腸癌の診断を補助する方法、大腸癌の診断のためにデータを収集する方法、大腸癌の診断用キット、大腸癌治療薬、大腸癌の治療方法、大腸癌の診断方法
US20160304961A1 (en) Method for predicting the response to chemotherapy treatment in patients suffering from colorectal cancer
JP2024035040A (ja) 分析方法、キット及び検出用デバイス
JPWO2015115544A1 (ja) 大腸がんの転移又は再発リスクの評価方法
WO2015105191A1 (ja) リンパ節腫脹病変の評価方法
EP4379064A1 (en) Diagnostic methods and diagnostic assay comprising detection of lncrnas
EP3717660B1 (en) Methods for evaluating head and neck cancers
EP4680743A1 (en) Methods of developing cancer diagnostic models and uses thereof in developing cancer detection methods
US20250298015A1 (en) Diagnostic method of detecting inflammation biomarker(s)
US20220291220A1 (en) Methods and compositions for detection and treatment of lung cancer
CN114790482A (zh) 一种筛查或辅助筛查结直肠癌的方法及其使用的miRNA组合
CN119570928A (zh) 用于结直肠癌诊断和预后预测的lncRNA组合
Shao et al. PP67 Early alpha-fetoprotein response predicts treatment efficacy of anti-angiogenic therapy in combination with metronomic chemotherapy for advanced hepatocellular carcinoma
CN112368399A (zh) miRNA用于高级别浆液性卵巢癌治疗护理的预测和预后用途
WO2015115545A1 (ja) 乳がんの転移又は再発リスクの評価方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20220712

RJ01 Rejection of invention patent application after publication